Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10885
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Seok Ming | - |
dc.contributor.author | Katsifis, Andrew | - |
dc.contributor.author | Villemagne, Victor L | - |
dc.contributor.author | Best, Rene | - |
dc.contributor.author | Jones, Gareth | - |
dc.contributor.author | Saling, Michael M | - |
dc.contributor.author | Bradshaw, Jennifer | - |
dc.contributor.author | Merory, John | - |
dc.contributor.author | Woodward, Michael M | - |
dc.contributor.author | Hopwood, Malcolm | - |
dc.contributor.author | Rowe, Christopher C | - |
dc.date.accessioned | 2015-05-16T00:27:45Z | |
dc.date.available | 2015-05-16T00:27:45Z | |
dc.date.issued | 2009-09-16 | - |
dc.identifier.citation | Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 2009; 50(10): 1638-45 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/10885 | en |
dc.description.abstract | Neuroimaging is increasingly used to supplement the clinical diagnosis of dementia with Lewy bodies (DLB) by showing reduced occipital metabolism and perfusion and reduced striatal dopaminergic innervation. We aimed to optimize the interpretation of (18)F-FDG PET images for differentiating DLB from Alzheimer disease (AD) and to compare the results with dopamine transporter imaging using (123)I-beta-carbomethoxy-3ss-(4-iodophenyl)tropane ((123)I-beta-CIT) SPECT.Fourteen subjects with a clinical diagnosis of DLB and 10 with AD underwent both (18)F-FDG PET and (123)I-beta-CIT SPECT. Four DLB and 1 AD diagnoses were subsequently confirmed at autopsy. Diagnostic accuracy was calculated for visual interpretation by 3 readers of standard 3-plane and stereotactic surface projection (18)F-FDG PET images, receiver-operating-characteristic analysis of regional (18)F-FDG uptake, and a cutoff value for the striatal-to-occipital binding ratio of beta-CIT defined by receiver-operating-characteristic analysis.Visual interpretation of 3-plane (18)F-FDG PET images had a sensitivity of 83% and specificity of 93% for DLB, slightly higher than the results with the stereotactic surface projection images. Regionally, hypometabolism in the lateral occipital cortex had the highest sensitivity (88%), but relative preservation of the mid or posterior cingulate gyrus (cingulate island sign) had the highest specificity (100%). Region-of-interest analysis revealed that occipital hypometabolism and relative preservation of the posterior cingulate both had a sensitivity of 77% and specificity of 80%. beta-CIT achieved 100% accuracy and greater effect size than did (18)F-FDG PET (Cohen d = 4.1 vs. 1.9).Both (18)F-FDG PET and (123)I-beta-CIT SPECT appear useful for the diagnosis of DLB, although the latter provides more robust results. The cingulate island sign may enhance the specificity of (18)F-FDG PET. | en |
dc.language.iso | en | en |
dc.subject.other | Aged | en |
dc.subject.other | Alzheimer Disease.metabolism.radionuclide imaging | en |
dc.subject.other | Autopsy | en |
dc.subject.other | Cocaine.analogs & derivatives.diagnostic use | en |
dc.subject.other | Cohort Studies | en |
dc.subject.other | Diagnosis, Differential | en |
dc.subject.other | Dopamine Plasma Membrane Transport Proteins.metabolism | en |
dc.subject.other | Female | en |
dc.subject.other | Fluorodeoxyglucose F18.diagnostic use | en |
dc.subject.other | Gyrus Cinguli.radionuclide imaging | en |
dc.subject.other | Humans | en |
dc.subject.other | Image Interpretation, Computer-Assisted | en |
dc.subject.other | Lewy Body Disease.metabolism.pathology.radionuclide imaging | en |
dc.subject.other | Male | en |
dc.subject.other | Positron-Emission Tomography | en |
dc.subject.other | ROC Curve | en |
dc.subject.other | Sensitivity and Specificity | en |
dc.subject.other | Staining and Labeling | en |
dc.subject.other | Tomography, Emission-Computed, Single-Photon | en |
dc.title | The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Journal of Nuclear Medicine | en |
dc.identifier.affiliation | Department of Nuclear Medicine and Centre for PET, Austin Health, Victoria, Australia | en |
dc.identifier.doi | 10.2967/jnumed.109.065870 | en |
dc.description.pages | 1638-45 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/19759102 | en |
dc.type.content | Text | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Rowe, Christopher C | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Clinical Neuropsychology | - |
crisitem.author.dept | The Florey Institute of Neuroscience and Mental Health | - |
crisitem.author.dept | Aged Care | - |
crisitem.author.dept | Geriatric Medicine | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.